Literature DB >> 28873355

Pulmonary interstitial glycogenosis associated with a spectrum of neonatal pulmonary disorders.

Ernest Cutz1, Rose Chami2, Sharon Dell3, Jacob Langer4, David Manson5.   

Abstract

Primary or isolated pulmonary interstitial glycogenosis (PIG) is a rare disease presenting as tachypnea and hypoxemia during the perinatal period. A diffuse interstitial infiltrate with focal hyperinflation is visible on chest imaging. The biopsy findings include diffuse expansion of the interstitium by spindle-shaped cells with pale cytoplasm that, on electron microscopy (EM), are poorly differentiated mesenchymal cells containing abundant monoparticulate glycogen. This glycogenosis appears to be a transient abnormality, usually with a favorable prognosis. Recently, cases of PIG, some associated with other pulmonary or systemic abnormalities, have been described. The clinical significance and potential role of PIG changes remain unknown. We report 28 cases of PIG associated with a spectrum of pediatric pulmonary and cardiovascular disorders, including arterial hypertensive changes with and without abnormal alveolar development (n=9), congenital heart disease (CHD; n=4), hyperplasia of pulmonary neuroendocrine cells resembling neuroendocrine hyperplasia of infancy (NEHI, n=5), congenital pulmonary airway malformation (n=5), congenital lobar emphysema (n=4), and Noonan syndrome (n=1). In all cases, PIG was confirmed by positive periodic acid-Schiff (PAS) staining, immunopositivity for vimentin, and EM. Although some patients improved with age, 7 died of respiratory failure or complications of CHD, suggesting that PIG may be clinically significant when associated with other severe disorders. The association of PIG with a spectrum of mostly congenital lung disorders supports its origin as a developmental abnormality of interstitial fibroblast differentiation rather than a nonspecific reactive process.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Congenital lung malformations; Lipofibroblasts; Neuroendocrine cell hyperplasia; Noonan syndrome; Pediatric interstitial lung disease

Mesh:

Year:  2017        PMID: 28873355     DOI: 10.1016/j.humpath.2017.06.026

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  5 in total

1.  Pulmonary interstitial glycogenosis: Diagnostic evaluation and clinical course.

Authors:  Deborah R Liptzin; Christopher D Baker; Jeffrey R Darst; Jason P Weinman; Megan K Dishop; Csaba Galambos; John T Brinton; Robin R Deterding
Journal:  Pediatr Pulmonol       Date:  2018-07-18

Review 2.  Recognizing genetic disease: A key aspect of pediatric pulmonary care.

Authors:  Lael M Yonker; Megan H Hawley; Peter P Moschovis; Mengdi Lu; T Bernard Kinane
Journal:  Pediatr Pulmonol       Date:  2020-07

3.  Rare neonatal interstitial lung disease masquerading as pulmonary hemosiderosis.

Authors:  Viraraghavan Vadakkencherry Ramaswamy; Sushma Nangia; Anu Thukral; Varinder Singh
Journal:  BMJ Case Rep       Date:  2019-04-24

4.  TGF-β1/IL-11/MEK/ERK signaling mediates senescence-associated pulmonary fibrosis in a stress-induced premature senescence model of Bmi-1 deficiency.

Authors:  Haiyun Chen; Hongjie Chen; Jialong Liang; Xin Gu; Jiawen Zhou; Chunfeng Xie; Xianhui Lv; Rong Wang; Qing Li; Zhiyuan Mao; Haijian Sun; Guoping Zuo; Dengshun Miao; Jianliang Jin
Journal:  Exp Mol Med       Date:  2020-01-21       Impact factor: 8.718

5.  Neonatal interstitial lung disease in a girl with Jacobsen syndrome: a case report.

Authors:  Marit Lunde Dalen; Natalya Filipchuk Vigerust; Clara Hammarström; Henrik Holmstrøm; Jannicke Hanne Andresen
Journal:  J Med Case Rep       Date:  2022-03-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.